 |
| Natalie Bauer, Ph.D. |
Her presentation, “Exosomes and Microparticles: Biomarkers, Therapeutic Vectors or Both,” was part of a session on Biomarker Discovery and Cell Therapy for Pulmonary Vascular Disorders in the Era of Precision Medicine. The 2023 conference was held in Devil's Thumb Ranch in Tabernash, Colorado.
“I gave an overview of the current status of the field and introduced some of our own new data on using extracellular vesicles as therapeutic vectors in pulmonary hypertension,” she said.
Bauer, the only speaker from the University of South Alabama this year, was selected through a competitive review process and chosen for her expertise in extracellular vesicle signaling and pulmonary vascular disease.
“The program is designed by investigators with expertise in precision medicine and pulmonary vascular disease and submitted through a competitive process for support through the American Thoracic Society,” she said. “The society reviews these applications annually and selects the most competitive slate of speakers to provide the most robust information to its membership.”
Since 1984, the Grover Conference has drawn the world’s best scientists and physicians in pulmonary circulation to its meetings. Named in honor of Robert F. Grover, a doctor and scientist devoted to the field, it is the longest-standing conference dedicated to pulmonary circulation.
The American Thoracic Society, which hosts the conference, improves global health by advancing research, patient care, and public health in pulmonary disease, critical illness, and sleep disorders. Founded in 1905 to combat TB, ATS has grown to tackle asthma, COPD, lung cancer, sepsis, acute respiratory distress, and sleep apnea, among other diseases.
